HEART ATTACKS FROM LOW T PRESCRIPTION TESTOSTERONE THERAPY
Testosterone treatments have surged in popularity in recent years due to the drugs’ purported benefits of treating men who suffer from hypogonadism, or Low-T. Testosterone products like AndroGel, Testim, Axiron, and Androderm are prescribed to help regulate testosterone levels and provide relief for a number of symptoms associated with low testosterone.
However, many males might not know that testosterone replacement therapy medications have been linked to an increased risk of serious health issues including heart attacks, strokes, and blood clots.
Talk to a Low T Lawsuit Lawyer
Are you interested in filing a Low T Lawsuit? Get a free consultation today.
LOW-T THERAPY INCREASES HEART ATTACK RISK
In the last several years a number of studies have found that testosterone products can increase the risk of heart attacks in males. In fact, some of the studies prompted the Food and Drug Administration (FDA) to announce that they would begin investigating the risk of heart attack in men using FDA-approved testosterone products and to reassess the safety of such treatments.
2014 Study: Low T Therapy Doubled the Risk of Heart AttackThe study published by PLOS One found that men, aged 65 and older, who use testosterone treatments, increased their risk of heart attack two-fold.
In the same study, they found that men below the age of 65 with heart disease increased their risk of non-fatal heart attack by as much as two to three times after taking testosterone treatments.
2013 Study: 30 Percent Increase Risk of Heart AttackA study published in the Journal of the American Medical Association was performed on 8,709 Veteran patients who had testosterone levels of less than 300 ng/dL and who had undergone coronary angiography—a procedure to assess for coronary artery disease—between 2005 and 2011. Some men in the study received testosterone products while others did not.
Although many of the men had underlying cardiovascular disease, the study found that 30 percent of those who were prescribed testosterone therapy increased their risk of heart attack.
2010 Study: Discontinued due to high rate of cardiovascular eventsThe New England Journal of Medicine study was conducted to determine if testosterone treatments increased muscle mass and strength in older men. For the study, men 65 years and older who suffered from limited mobility were randomly assigned to receive a placebo gel or testosterone gel that would be applied daily for 6 months.
The study had to be discontinued early due to the research finding a significantly higher rate of adverse cardiovascular events in the testosterone group compared to the placebo group.
INCREASED RISK OF HEART ATTACKS IN OLDER MEN
Testosterone treatments are marketed as a way to combat the effects of aging and provide older men with increased strength and bone density, energy levels, and improved sex drive. However, older men who use these products are at a higher risk for adverse health events compared to younger males.
A study supported by the National Cancer Institute analyzed the results of testosterone treatments on 56,000 men. The study found that men 65 years and older increased their risk of heart attacks two-fold.
Furthermore, the research study showed that most heart attacks occurred in the first 90 days after a prescription was written. Doctors suggest that heart attacks do not normally develop in such a short period of time, indicating that the testosterone treatments could be the major factor contributing to the heart problems that were observed
LAWSUITS FOR HEART ATTACKS FROM LOW-T THERAPYThere have been a number of lawsuits filed related to heart attacks from prescription testosterone.
In 2012, a New Jersey man who began using the testosterone product, Axiron, suffered a heart attack within one month of beginning treatment. The plaintiff is now suing Axiron makers, Eli Lilly & Co., alleging that their aggressive marketing campaign did not give adequate warning about the possible serious side effects.
In 2014, a number of lawsuits were filed against AndroGel’s manufacturer, AbbVie. One man is seeking damages for physical and emotional damage after suffering a heart attack while using AndroGel.
In addition to this particular case, many men claim that AbbVie used aggressive marketing tactics that made otherwise healthy men believe they had a disorder and needed to be treated with testosterone products.
Low Testosterone Treatment Heart Attack Lawsuits
Although testosterone treatments are prescribed to treat hypogonadism, healthy men are being targeted to treat symptoms that are associated with the normal aging process. The manufacturers of products including Androgel, Androderm, Axiron, and Testim, are being sued by thousands of those who claim that the pharmaceutical companies use aggressive marketing tactics and do not provide enough warning about the serious health risks associated with using testosterone treatments.
If you or a loved one suffered a serious cardiovascular side effect while undergoing treatment for low testosterone, you may be eligible for financial compensation for your injuries. We are offering free testosterone lawsuit evaluations to all individuals who feel that they have been harmed by these dangerous drugs – we are here to help. Contact us today at 1-215-923-9300 or use the form below.
The use of this contact form does not create an attorney-client relationship and is for informational purposes to determine if you have a valid case. For more information or to speak directly with an attorney, please contact us at 1-215-923-9300.